Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Financials | 8.97% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Limbach Holdings
LMB
$527M
| $30.6M | 0.05% |
358,271
-3,800
| -1% | -$335K |
|
477
Xylem
XYL
$28.1B
| $30.6M | 0.05% |
263,471
+31,500
| +14% | +$3.98M |
|
478
Universal Technical Institute
UTI
$1.42B
| $30.6M | 0.05% |
1,188,891
+6,743
| +0.6% | +$140K |
|
479
Regency Centers
REG
$14.1B
| $30.5M | 0.05% |
412,523
-75,600
| -15% | -$5.53M |
|
480
Janus Henderson B-BBB CLO ETF
JBBB
$1.43B
| $30.5M | 0.05% |
619,900
+331,600
| +115% | +$16.3M |
|
481
Pan American Silver
PAAS
$19.9B
| $30.3M | 0.04% |
1,498,246
+784,906
| +110% | +$17.6M |
|
482
Banco de Chile
BCH
$20.5B
| $30.3M | 0.04% |
1,335,194
+29,300
| +2% | +$690K |
|
483
State Street Health Care Select Sector SPDR ETF
XLV
$44B
| $30.3M | 0.04% |
220,100
+54,400
| +33% | +$7.96M |
|
484
W.W. Grainger
GWW
$62.2B
| $30.3M | 0.04% |
28,700
-35,000
| -55% | -$39.4M |
|
485
Synchrony
SYF
$26.1B
| $30.2M | 0.04% |
465,100
+45,100
| +11% | +$2.76M |
|
486
Baidu
BIDU
$35.5B
| $30.2M | 0.04% |
358,399
-104,500
| -23% | -$9.54M |
|
487
Maximus
MMS
$2.94B
| $30.1M | 0.04% |
403,600
+161,400
| +67% | +$13.2M |
|
|
DVAX
488
DELISTED
Dynavax Technologies
DVAX
| $30.1M | 0.04% |
2,355,278
+41,000
| +2% | +$496K |
|
489
Norfolk Southern
NSC
$75.9B
| $30M | 0.04% |
128,000
+80,300
| +168% | +$20.4M |
|
490
Quanex
NX
$981M
| $29.8M | 0.04% |
1,231,341
-25,466
| -2% | -$730K |
|
491
Watsco Inc
WSO
$12.9B
| $29.6M | 0.04% |
62,400
+35,800
| +135% | +$18.1M |
|
492
Legend Biotech
LEGN
$3.93B
| $29.5M | 0.04% |
908,100
+890,000
| +4,917% | +$36.9M |
|
493
PTC Therapeutics
PTCT
$6.01B
| $29.5M | 0.04% |
653,100
+114,900
| +21% | +$4.92M |
|
494
GeoPark
GPRK
$608M
| $29.4M | 0.04% |
3,176,376
+156,067
| +5% | +$1.39M |
|
495
Acuity Brands
AYI
$10.8B
| $29.2M | 0.04% |
100,100
+18,600
| +23% | +$5.81M |
|
|
496
Meta Platforms (Facebook)
META
$1.52T
| $29.2M | 0.04% |
49,858
-597,566
| -92% | -$351M |
|
|
CVSA
497
Covista Inc
CVSA
$4.49B
| $28.9M | 0.04% |
317,800
+57,000
| +22% | +$4.77M |
|
498
Masco
MAS
$14.7B
| $28.8M | 0.04% |
397,300
+51,600
| +15% | +$4.13M |
|
499
Walmart Inc
WMT
$921B
| $28.8M | 0.04% |
318,970
-664,756
| -68% | -$57.7M |
|
500
Omega Healthcare
OHI
$13.9B
| $28.8M | 0.04% |
760,205
+55,027
| +8% | +$2.2M |
|
Similar funds
Jim Simons's Q4 2024 Portfolio in Review
As of Q4 2024, Jim Simons held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Jim Simons's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Jim Simons added most to Alibaba in Q4 2024, an estimated $191M increase.
- Jim Simons's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Jim Simons fully exited Arm in Q4 2024, selling an estimated $153M.
- Jim Simons's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Jim Simons opened 548 new positions and closed 497 in Q4 2024.
- Jim Simons's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.